Biotech | October 07, 2025
Lonza expands cell and gene therapy portfolio
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
Investment to expand manufacturing and global medicine supply capacity
A Post Graduate in Science faculty and has a wide experience spanning over 35 years in the field of manufacturing Bulk Drugs and Active Pharmaceutical Intermediaries
India currently hosts more than 10,075 biotech startups
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
No post-injection Delirium/Sedation Syndrome (PDSS) observed through 56 weeks
The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Products manufactured at the new Vaughan facility will support research in areas including cancer, infectious disease, mental health, and environmental safety
Sun Pharma's Halol plant gets OAI classification from US FDA inspection
Subscribe To Our Newsletter & Stay Updated
